What Analyst Projections for Key Metrics Reveal About Charles River (CRL) Q4 Earnings

Core Insights - The upcoming earnings report for Charles River Laboratories (CRL) is anticipated to show a quarterly earnings per share (EPS) of $2.33, reflecting a decline of 12.4% year-over-year [1] - Revenue is forecasted to be $985.92 million, indicating a decrease of 1.7% compared to the previous year [1] Earnings Estimates - The consensus EPS estimate has been revised 0.1% higher in the last 30 days, indicating a collective reevaluation by analysts [2] - Changes in earnings estimates are crucial for predicting investor reactions, as empirical research shows a strong correlation between earnings estimate revisions and short-term stock performance [3] Revenue Projections - Analysts project 'Revenue- Research Models and Services' to be $202.12 million, a decrease of 1% year-over-year [5] - The estimate for 'Revenue- Manufacturing Solutions' is $199.51 million, reflecting a year-over-year increase of 2.3% [5] - 'Revenue- Discovery and Safety Assessment' is expected to reach $585.53 million, indicating a decline of 3% from the previous year [5] Operating Income Estimates - 'Operating income- Research Models and Services- Non-GAAP' is expected to be $42.04 million, down from $46.54 million in the same quarter last year [6] - 'Operating income- Discovery and Safety Assessment- Non-GAAP' is projected at $142.16 million, compared to $148.98 million in the previous year [6] - 'Operating income- Manufacturing Solutions- Non-GAAP' is estimated to be $50.75 million, down from $55.91 million year-over-year [7] - The average prediction for 'Operating income- Research Models and Services' is $30.77 million, compared to $13.77 million in the same quarter last year [7] - 'Operating income- Discovery and Safety Assessment' is expected to reach $107.95 million, up from $62.86 million in the previous year [8] Stock Performance - Charles River shares have decreased by 26.6% in the past month, contrasting with the Zacks S&P 500 composite's decline of 1.7% [8] - The company holds a Zacks Rank 3 (Hold), suggesting it is expected to closely follow overall market performance in the near term [8]